Antimicrobial Agents and Chemotherapy · 1981 · 32 citations · 10 references
MedicinePharmacologyPharmacotherapyAntimicrobial PharmacologyAntimicrobial PharmacotherapyRespiratory PharmacotherapyAntimicrobial Penetration Into TissuesPharmacokinetics Of AntimicrobialsRespiratory PharmacologyBactericidal AgentsBronchial SecretionsPharmacodynamics Of AntibioticsPseudomonas SpeciesRespiratory Bacterial Infections TreatmentTracheal SecretionsTracheobronchial Disease
The penetration of amikacin and tobramycin into bronchial secretions and the resulting anti-Pseudomonas activity were assessed in two groups of tracheostomized or intubated patients with tracheobronchial infection and purulent bronchial secretions. The aminoglycosides were administered as continuous, high-dose intravenous infusions. The mean drug concentrations in serum and bronchial secretions were 12.8 and 2.0 microgram/ml for amikacin and 3.6 and 0.7 microgram/ml for tobramycin. The bronchial secretion/serum ratios varied over a wide range: from 9.6 to 22.8% (average, 14.9%) for amikacin and from 3 to 39.3% (average, 17.5%) for tobramycin. Sustained anti-Pseudomonas activities in bronchial secretions were achieved only in patients with very high aminoglycoside levels in serum. In most patients, however, no anti-Pseudomonas activity could be detected within bronchial secretions despite therapeutic levels of amikacin and tobramycin and adequate bactericidal activities in serum.
10
Simplified, Accurate Method for Antibiotic Assay of Clinical Specimens
John V. Bennett, Jean L. Brodie, E. Jack Benner et al. · Applied Microbiology · 1966 · 922 citations · Full text
Penetration of antimicrobial agents into bronchial secretions
Gail A. Wong, T. H. Peirce, Elliot Goldstein et al. · The American Journal of Medicine · 1975 · 77 citations